Specific Nutritional Biomarker Profiles in Mild Cognitive Impairment and Subjective Cognitive Decline Are Associated With Clinical Progression: The NUDAD Project

F.A. de Leeuw*, W.M. van der Flier, B.M. Tijms, P. Scheltens, V.M. Mendes, B. Manadas, J. Bierau, N. van Wijk, E.G.H.M. van den Heuvel, M.H. Mohajeri, C.E. Teunissen, M.I. Kester

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1513.e1-1513.e17
Number of pages17
JournalJournal of the American Medical Directors Association
Volume21
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Keywords

  • alzheimers-disease
  • cerebrospinal-fluid
  • clinical progression
  • cognitive decline
  • dementia
  • diagnostic guidelines
  • mild cognitive impairment
  • national institute
  • nutrients
  • nutritional biomarker
  • nutritional biomarker profiles
  • plasma
  • risk
  • s-adenosylmethionine
  • serum
  • subjective cognitive decline
  • total cholesterol levels
  • DEMENTIA
  • ALZHEIMERS-DISEASE
  • TOTAL CHOLESTEROL LEVELS
  • CEREBROSPINAL-FLUID
  • NATIONAL INSTITUTE
  • PLASMA
  • Nutrients
  • RISK
  • SERUM
  • S-ADENOSYLMETHIONINE
  • DIAGNOSTIC GUIDELINES

Cite this